Hims & Hers Health, Inc. (NYSE:HIMS) has entered Australia, marking its first expansion into the Asia-Pacific market. The move follows its acquisition of Australian digital-health platform Eucalyptus, which includes men's health brand Pilot and women's health brand Juniper. Hims is initially rolling out weight-loss and men's health treatments, with plans to introduce women's health services later this year.
The Australian launch allows Hims & Hers Health, Inc. (NYSE:HIMS) to replicate its U.S. and European model in another large, digitally connected healthcare market. It also gives the company access to local infrastructure and clinical expertise rather than requiring it to build the business entirely from scratch. The company has said international expansion has already helped increase monthly revenue per subscriber by 21% year over year, although international growth has also pressured gross margins.
Australia could become another meaningful growth engine for Hims & Hers Health, Inc. (NYSE:HIMS) as the company expands beyond its core U.S. market. The acquisition of Eucalyptus gives Hims an established local presence, existing brands and clinicians, which should reduce some of the execution risk normally ******* ociated with entering a new country.
The opportunity is particularly attractive because Hims can introduce multiple healthcare categories rather than relying on a single product. Weight loss, men's health, and eventually women's health give the company several avenues to increase customer acquisition and spending per subscriber. Combining services Australians previously purchased separately could also increase customer lifetime value.
The Australian market could also strengthen Hims' international scale. The company has already expanded into Europe through its acquisition of Zava, and Australia provides another market in which the company can leverage its technology, brand and telehealth infrastructure. If Hims & Hers Health, Inc. (NYSE:HIMS) can successfully replicate its customer-acquisition model internationally, the Australian business could become an important contributor toward its long-term $6.5 billion revenue target for 2030.
#Health #company #acquisition #australia
The Australian launch allows Hims & Hers Health, Inc. (NYSE:HIMS) to replicate its U.S. and European model in another large, digitally connected healthcare market. It also gives the company access to local infrastructure and clinical expertise rather than requiring it to build the business entirely from scratch. The company has said international expansion has already helped increase monthly revenue per subscriber by 21% year over year, although international growth has also pressured gross margins.
Australia could become another meaningful growth engine for Hims & Hers Health, Inc. (NYSE:HIMS) as the company expands beyond its core U.S. market. The acquisition of Eucalyptus gives Hims an established local presence, existing brands and clinicians, which should reduce some of the execution risk normally ******* ociated with entering a new country.
The opportunity is particularly attractive because Hims can introduce multiple healthcare categories rather than relying on a single product. Weight loss, men's health, and eventually women's health give the company several avenues to increase customer acquisition and spending per subscriber. Combining services Australians previously purchased separately could also increase customer lifetime value.
The Australian market could also strengthen Hims' international scale. The company has already expanded into Europe through its acquisition of Zava, and Australia provides another market in which the company can leverage its technology, brand and telehealth infrastructure. If Hims & Hers Health, Inc. (NYSE:HIMS) can successfully replicate its customer-acquisition model internationally, the Australian business could become an important contributor toward its long-term $6.5 billion revenue target for 2030.
#Health #company #acquisition #australia
2 months ago
